The present invention is directed to pyridine compounds of Formula (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds as therapeutic agents treating neurological and psychiatric disorders.La présente invention concerne des composés pyridines de formule (I). Des aspects séparés de l'invention concernent des compositions pharmaceutiques comprenant lesdits composés et des utilisations des composés en tant qu'agents thérapeutiques traitant des troubles neurologiques et psychiatriques.